Parallel Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-350
Closed -$7.42K 3427
2022
Q4
$7.42K Buy
350
+327
+1,422% +$6.78K ﹤0.01% 2157
2022
Q3
$0 Hold
23
﹤0.01% 3159
2022
Q2
$1K Hold
23
﹤0.01% 2709
2022
Q1
$0 Hold
23
﹤0.01% 2989
2021
Q4
$0 Hold
23
﹤0.01% 3095
2021
Q3
$0 Hold
23
﹤0.01% 3083
2021
Q2
$0 Hold
23
﹤0.01% 2942
2021
Q1
$0 Hold
23
﹤0.01% 2797
2020
Q4
$0 Hold
23
﹤0.01% 2573
2020
Q3
$1K Hold
23
﹤0.01% 2412
2020
Q2
$0 Sell
23
-124
-84% -$3.06K ﹤0.01% 2457
2020
Q1
$3K Buy
+147
New +$3.5K ﹤0.01% 2013
2019
Q3
Sell
-71
Closed -$2K 2399
2019
Q2
$2K Hold
71
﹤0.01% 2062
2019
Q1
$2K Sell
71
-65
-48% -$1.38K ﹤0.01% 2060
2018
Q4
$3K Buy
+136
New +$2.9K ﹤0.01% 1716

Other funds holding BTAL

Parallel Advisors's BTAL Position: Q1 2023 in Review

Parallel Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 350 shares — an estimated $7.42K sold.

Parallel Advisors first reported a position in BTAL in Q4 2018 and held it in 15 quarters. The position peaked at $7.42K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.

  • Parallel Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
  • Parallel Advisors sold 350 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $7.42K.
  • Parallel Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and held it in 15 quarters.
  • Parallel Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $7.42K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.